
13/01/2024
Repost from: Dr Sarah Buckley
More juicy New Year publications. This huge population (in real life) study from Victoria, Australia, found that elective induction of labour (no medical indication) in low-risk first-time pregnancies increases the risk of cesarean section by 31% at 39 weeks, 42% at 40 weeks, 43% at 41 weeks. They found very small benefits for the baby, which are statistically non-significant below 41 weeks. (At 41 weeks, induction (vs expectant management) reduced perinatal mortality by less than 1 per thousand.) This is a really important balance to the ARRIVE trial findings and suggests that the supposed benefits of ARRIVE may not apply IRL- ie outside of randomised studies. Full text here, -with great critique of ARRIVE https://onlinelibrary.wiley.com/doi/full/10.1111/birt.12806?campaign=wolearlyview
PS you can read my critique of the ARRIVE trial here https://sarahbuckley.com/should-every-mother-be-induced-the-arrive-trial/
More juicy New Year publications. This huge population (in real life) study from Victoria, Australia, found that elective induction of labour (no medical indication) in low-risk first-time pregnancies increases the risk of cesarean section by 31% at 39 weeks, 42% at 40 weeks, 43% at 41 weeks. They found very small benefits for the baby, which are statistically non-significant below 41 weeks. (At 41 weeks, induction (vs expectant management) reduced perinatal mortality by less than 1 per thousand.) This is a really important balance to the ARRIVE trial findings and suggests that the supposed benefits of ARRIVE may not apply IRL- ie outside of randomised studies. Full text here, -with great critique of ARRIVE https://onlinelibrary.wiley.com/doi/full/10.1111/birt.12806?campaign=wolearlyview
PS you can read my critique of the ARRIVE trial here https://sarahbuckley.com/should-every-mother-be-induced-the-arrive-trial/